HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roberto Diletti Selected Research

Drug-Eluting Stents

7/2022Impact of thrombus burden on long-term clinical outcomes in patients with either anterior or non-anterior ST-segment elevation myocardial infarction.
1/2022PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY.
1/2022Elastic stent recoil in coronary total occlusions: Comparison of durable-polymer zotarolimus eluting stent and ultrathin strut bioabsorbable-polymer sirolimus eluting stent.
1/2021Efficacy and Safety of Ticagrelor Monotherapy by Clinical Presentation: Pre-Specified Analysis of the GLOBAL LEADERS Trial.
1/2020Long-term outcome in patients treated with first- versus second-generation drug-eluting stents for the treatment of unprotected left main coronary artery stenosis.
8/2016Current and novel approaches to treat patients presenting with ST elevation myocardial infarction.
5/2016Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI first study.
1/2014Impact of biodegradable versus durable polymer drug-eluting stents on clinical outcomes in patients with coronary artery disease: a meta-analysis of 15 randomized trials.
6/2013Progress in treatment by percutaneous coronary intervention: the stent of the future.
1/2013Bioresorbable scaffolds in the treatment of coronary artery disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Roberto Diletti Research Topics

Disease

27Thrombosis (Thrombus)
01/2022 - 12/2011
25ST Elevation Myocardial Infarction
10/2022 - 01/2013
17Myocardial Infarction
11/2022 - 03/2015
17Cardiovascular Diseases (Cardiovascular Disease)
07/2022 - 07/2011
13Coronary Artery Disease (Coronary Atherosclerosis)
04/2022 - 01/2013
8Acute Coronary Syndrome
11/2022 - 07/2013
7Hemorrhage
01/2022 - 04/2012
7Death (Near-Death Experience)
01/2022 - 07/2011
6Infarction (Infarctions)
12/2020 - 07/2011
5Stroke (Strokes)
11/2022 - 06/2019
4Pathologic Constriction (Stenosis)
01/2020 - 08/2013
3Neointima
11/2020 - 12/2011
3Prolapse
10/2016 - 01/2012
3Atherosclerotic Plaque (Atheroma)
12/2013 - 07/2011
3Inflammation (Inflammations)
06/2013 - 07/2012
2Ischemia
11/2022 - 07/2011
2Coronary Stenosis (Coronary Artery Stenosis)
01/2020 - 01/2020
2Hyperemia
01/2020 - 01/2019
2Foreign Bodies (Foreign Body)
03/2015 - 01/2013
2Delayed Hypersensitivity (Hypersensitivity, Type IV)
08/2013 - 06/2013
1Hyperplasia
11/2020
1Hematoma
10/2020
1Shock
03/2020
1Cardiogenic Shock
03/2020
1Kidney Diseases (Kidney Disease)
01/2017
1Chest Pain (Chest Pains)
01/2017
1Chronic Renal Insufficiency
01/2017
1Coronary Disease (Coronary Heart Disease)
01/2017
1Renal Insufficiency (Renal Failure)
01/2017
1Wounds and Injuries (Trauma)
02/2016
1Atherosclerosis
03/2015
1Hypersensitivity (Allergy)
03/2015
1Vascular System Injuries
05/2013
1Chronic Obstructive Pulmonary Disease (COPD)
12/2012
1Peripheral Vascular Diseases (Peripheral Vascular Disease)
12/2012
1Peptic Ulcer (Peptic Ulcers)
12/2012
1Myocardial Ischemia (Ischemic Heart Diseases)
11/2012
1Fibrosis (Cirrhosis)
07/2012

Drug/Important Bio-Agent (IBA)

18omega-Chloroacetophenone (Mace)IBA
11/2022 - 02/2012
9EverolimusFDA Link
01/2021 - 12/2011
7Prasugrel HydrochlorideFDA Link
10/2022 - 01/2016
6TicagrelorIBA
01/2022 - 01/2016
5PolymersIBA
01/2021 - 06/2013
4TabletsIBA
10/2022 - 01/2020
4bivalirudin (Angiomax)FDA Link
11/2020 - 08/2017
32'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
01/2022 - 06/2017
3MetalsIBA
01/2021 - 05/2016
3Heparin (Liquaemin)FDA LinkGeneric
11/2020 - 08/2017
2CreatinineIBA
01/2022 - 12/2012
2Pharmaceutical PreparationsIBA
01/2020 - 09/2016
2Phenobarbital (Luminal)FDA Link
11/2015 - 12/2013
1Dihydrotachysterol (AT 10)IBA
01/2022
1CholesterolIBA
01/2021
1Sirolimus (Rapamycin)FDA Link
01/2020
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2020
1Adenosine (Adenocard)FDA LinkGeneric
01/2019
1ThrombinFDA Link
08/2017
1TroponinIBA
01/2017
1trans-crotonin (CTN)IBA
01/2017
1Troponin T (Troponin T1)IBA
01/2017
1Biomarkers (Surrogate Marker)IBA
01/2013
1nitinolIBA
12/2012
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
12/2012
1Amiodarone (Amiodarona)FDA LinkGeneric
12/2012
1FibrinIBA
07/2012
1Contrast MediaIBA
04/2012

Therapy/Procedure

40Stents
01/2022 - 07/2011
31Percutaneous Coronary Intervention
07/2022 - 01/2013
11Therapeutics
01/2022 - 12/2012
10Drug-Eluting Stents
07/2022 - 01/2013
2Duration of Therapy
11/2020 - 12/2019
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
11/2022
1Oral Administration
01/2021
1Investigational Therapies (Experimental Therapy)
11/2019
1Secondary Prevention
01/2018
1Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
01/2018
1Ischemic Postconditioning
10/2016
1Punctures
02/2016
1Stem Cell Transplantation
08/2014
1Transcatheter Aortic Valve Replacement
08/2013
1Prostheses and Implants (Prosthesis)
06/2013
1Catheters
04/2012
1Myocardial Revascularization
07/2011